Fosamax Lawsuit Update: Merck Allegedly Hid Risks of Fosamax , Parker Waichman LLP Recounts There are over 3,000 lawsuits alleging that Merck’s osteoporosis drug Fosamax (alendronate) causes bone fractures. The first lawsuit alleging such injuries went to trial this week in New Jersey state court; according to Bloomberg, attorneys for Plaintiff Christina Su allege that Merck knew Fosamax could weaken bones and hid this risk from regulators. ... [News Source]